Comparing knowledge of β-thalassemia in samples of Italians, Italian-Americans, and non-Italian-Americans

Journal of Genetic Counseling

Volumn 14, Issue 5, 2005, Pages 365-376

  Armeli, Christina ^a   Robbins, Steven J ^a   Eunpu, Deborah ^a  

^a ARCADIA UNIVERSITY   (United States)

Author keywords

Awareness; Beta ( ) thalassemia; Screening; Sicily

Indexed keywords

ADULT; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DOWN SYNDROME; EDUCATION PROGRAM; FEMALE; HUMAN; ITALY; MALE; NORMAL HUMAN; POPULATION DYNAMICS; QUESTIONNAIRE; RISK ASSESSMENT; UNITED STATES;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; BETA-THALASSEMIA; DOWN SYNDROME; FEMALE; GENETIC SCREENING; HUMANS; ITALY; MALE; MIDDLE AGED; QUESTIONNAIRES; UNITED STATES;

EID: 26044459928     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-005-1123-5     Document Type: Article

References (16)

1. Atkin, K., & Ahmad, W. I. U. (1998). Genetic screening and haemoglobinopathies: Ethics, politics, and practice. Soc Sci Med, 46, 445-458.
2. Cao, A., Furbetta, M., Galanello, M., Melis, A., Angius, A., Ximenes, A., et al. (1981). Prevention of homozygous β-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Amer J Hum Genet, 33, 592-605.
3. Cao, A., Pintua, L., Lecca, U., Olla, G., Cossu, P., Rosatelli, C., & Galanello, R. (1984). Control of homozygous β-Thalassemia by carrier screening and antenatal diagnosis in Sardinians. Clin Genet, 26, 12-22.
4. Cao, A., Rosatelli, C., Galanello, R., Monni, G., Olla, G., Cossu, P., & Ristaldi, M. (1989). The prevention of thalassemia in Sardinia. Clin Genet, 36, 277-285.
5. Cao, A., Saba, L., Galanello, R., & Rosatelli, M. (1997). Molecular diagnosis and carrier screening for β-thalassemia. J Amer Med Assoc, 278, 1273-1277.
6. Capua, A. (1998). The Montreal thalassemia screening program. Ann NY Acad Sci, 850, 401-403.
7. Goldberg, I. V. (2001). Genetic information privacy and discrimination. Health Care Manag, 20, 19-28.
8. Krumm, J. (2002). Genetic discrimination: Why Congress must ban genetic testing in the workplace. J Legal Med, 23, 491-521.
9. Kunkel, H. G., Ceppellini, R., Muller-Eberhard, V., & Wolf, J. (1957). Observations on the minor basic hemoglobin component in the blood of normal individuals and patients with thalassemia. J Clin Invest, 36, 1615-1625.
10. Mitchell, J., Capua, A., Clow, C., & Scriver, C. (1996). Twenty-year outcome analysis of genetic screening programs for taysachs and β-thalassemia disease carriers in high schools. Amer J Hum Genet, 59, 793-798.
11. Olivieri, N. (1999). Medical progress: The (beta)-thalassemias. New Engl J Med, 341, 99-109.
12. Rowley, P., Lipkin, M., & Fisher, L. (1984). Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: Comparison of three counseling methods. Amer J Hum Genet, 36, 677-689.
13. Rowley, P., Fisher, L., & Lipkin, M. (1979). Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: Effects on knowledge and mood. Amer J Hum Genet, 31, 718-730.
14. Roche, P. A., & Annas, G. J. (2001). Protecting genetic privacy. Nat Rev Genet, 2, 392-396.
15. Sankar, P. (2003). Genetic privacy. Annu Rev Med, 54, 393-407.
16. Wiesenthal, D. L., & Wiener, N. I. (1996). Privacy and the human genome project. Ethics Behav, 6, 189-201.